AzTrials
AzTrials

MRI ScansNCT02318550

Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD

An observational study of MRI Scans and Magnetic Resonance Imaging, run by Lancaster General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
MRI Scans, Magnetic Resonance Imaging, Pacemaker
What is being tested?
MRI Scan
How many people
262 participants
Where
1 siteUnited States
Study dates
Dec 2014to 30 Jun 2018
How long will I take part?
6 Months
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Any patient with any commercially available pacemaker or ICD system implanted after 2001 who meet all of the inclusion criteria and none of the exclusion criteria, and who require a non-cardiac, medically-indicated MRI as described above will be eligible to enroll in the study.

Who may be able to join

None listed.

Who cannot join

  • Non-device related contraindication for MRI (such as implanted metallic objects, claustrophobia, morbid obesity)
  • Presence of capped/abandoned/epicardial leads or subcutaneous coil
  • Pregnancy
  • Device generator at elective replacement interval
  • Abdominal device implant

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Lancaster General Hospital

    Lancaster, Pennsylvania, 17604

Other trials in United States

About this study

Official title: A Single Institution Registry Trial Evaluating the Safety of MRI for Patients With Non-MRI Conditional Pacemakers and ICD

The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.

Read the detailed description

Registry Purpose

This registry is a prospective single institution study of MRI examinations in patients with pacemakers or ICD's who will undergo an MRI that is ordered for routine clinical care. The purpose of the registry is to accumulate pre-and post-scan device interrogation data for the purpose of determining the risk of MRI for patients with implantable devices.

Registry data will add to existing data on the safety of MRI scans for patients with pacemakers and ICDs. This safety data may impact physicians' diagnostic choices for this patient population. Patients with conditions for whom MRI is the best diagnostic modality but who have not been able to undergo MRI scanning may be able to do so through registry participation. The diagnostic information obtained from the scan may assist physicians' treatment decisions and may ultimately affect patient outcomes.

In addition, to our knowledge, previous registries of MRI's in non-conditional cardiac devices have been limited to academic centers. This registry would be among the first to demonstrate the feasibility and safety of this approach in a community hospital setting.

Study Methods

The registry research involves acquiring and analyzing the data of device function and adverse events related to the MRI scan.

The need for MRI will be determined on a case-by-case basis based on the patient's medical history and treatment plan/goals, independent of the registry and research purposes. Only patients with implanted devices with orders for clinically indicated MRI scans will be considered for registry inclusion. Clinical review will be performed and the patient considered after determination that no other imaging modality would be appropriate.

The appropriateness of the MRI study must be discussed, in person or via phone call, between a cardiac radiologist, as determined by Paul Leslie, M.D., and the requesting physician. The discussion should include consideration of alternative imaging modalities and diagnostic quality of MRI imaging of requested body region given implanted device(s). The requesting physician is then responsible for discussing with the patient and/or their medical proxy the reasoning for the determination, based on the final decision made by a radiologist.

All patients will be screened prior to enrollment. Any patient with any commercially available pacemaker or ICD system implanted after 2001 who meet all of the inclusion criteria and none of the exclusion criteria, and who require a medically-indicated MRI as described above will be eligible to enroll in the study. The presence/absence of capped/abandoned/epicardial leads/subcutaneous coil will be confirmed and documented by review of the most recent chest x-ray obtained. The x-ray must post-date the most recent device/lead intervention, as determined by a review of the patient's medical record.

If an MRI procedure is deemed absolutely necessary, the MRI will be performed at the Lancaster General Hospital Lime Street MRI facility. MRI scan sequences, field intensity and field(s) of exposure will be selected to minimize risk to the patient while gaining needed diagnostic information for diagnosis or therapy management.

The MRI will be performed with a 1.5 T scanner utilizing institutional protocols and the following settings:

  • Normal operating mode
  • SAR ≤ 2.0 W/kg per patient.

Prior to the procedure, a pacemaker technologist or manufacturer clinical representative will interrogate the pacemaker or ICD and record the following parameters:

  • Patient's underlying rhythm
  • Atrial and right/left ventricular pacing thresholds
  • P-wave and R-wave amplitude
  • Lead impedance (atrial, ventricular, high voltage)
  • Battery voltage
  • Arrhythmia history
  • Tachyarrhythmia therapy

The following pacemaker/ICD parameters will be deactivated for the duration of the MRI:

  • Magnet response (ICD)
  • Rate response
  • PVC response
  • Noise reversion response
  • Ventricular sense response
  • Mode switching
  • Tachycardia detection/therapies (ICD)
  • EGM triggers

Patients who are not pacemaker dependent will have their pacemaker/ICD programmed to AAI/VVI/DDI at 40 beats per minute for the duration of the MRI. Patients who are pacemaker dependent (pacing at programmed lower rate during the pre-scan interrogation) will have their pacemaker/ICD programmed to AOO/VOO/DOO at the programmed lower rate for the duration of the MRI. Emergency equipment, including a MRI compatible defibrillator and transcutaneous pacemaker, will be available throughout the procedure in the event of an adverse clinical event. In addition to radiology staff, a pacemaker technologist or manufacturer clinical representative and an EP tech/RN with current ACLS will be present for the duration of the procedure. An EP physician/advanced practice provider (APP) must be immediately available (i.e., in the hospital) to provide medical intervention, such as placement of a temporary external pacemaker if required. In the event that a code is called by the MRI staff, hospital protocol indicates that ER staff will respond to the code.

Radiology staff and the electrophysiology (EP) technologist or nurse with current ACLS certification will monitor the following patient parameters at least every 5 minutes throughout the MRI scan:

  • Heart rate
  • Heart rhythm
  • Non-invasive blood pressure
  • Oxygen saturation
  • Symptoms

If any of the following adverse symptoms/events occur during the scan, the test will be immediately terminated:

  • Burning/pulling sensation in device pocket/chest during MRI
  • Potentially lethal/previously non-diagnosed arrhythmias during MRI
  • Spontaneous and unanticipated pacing rate change
  • SOB
  • Chest pain
  • Feeling of heat/pulling in the chest or device pocket

The patient will be removed from the scanner to the holding area and the device interrogated and reprogrammed to original parameters or as indicated by interrogation. If needed, emergency treatment will be provided as per ACLS protocols or at the discretion of the monitoring physician. The following parameters will be compared to the pre-MRI results:

  • Patient's underlying rhythm
  • Atrial and right/left ventricular pacing thresholds
  • P-wave and R-wave amplitude
  • Lead impedance (atrial, ventricular, high voltage)
  • Battery voltage

All device-related adverse events/symptoms will be documented on the data collection form and reported to the IRB. The patient will remain in the MRI suite holding area until medically stable. The need for further treatment will be at the discretion of the monitoring physician.

The EP physician/APP will review and compare the pre/post MRI device data prior to the patient's discharge from the MRI suite. Following testing, the pacemaker or ICD will be reprogrammed to the pre-procedure parameters. The need for device reprogramming related to the MRI scan will be based on the clinical judgment of the attending electrophysiologist.

Follow-up

Patients who do not experience any device related adverse events during the MRI will return for one follow-up visit 1-6 weeks after the MRI. The follow-up visit will include pacemaker/ICD interrogation and testing to confirm appropriate function. At a minimum, device interrogation/testing will include:

  • Atrial and right/left ventricular pacing thresholds
  • P-wave and R-wave amplitude
  • Lead impedance (atrial, ventricular, high voltage)
  • Battery voltage

Patients who experience one or more device-related adverse events during the MRI will return 1-7 days post-MRI for follow-up pacemaker/ICD testing to confirm appropriate function. At a minimum, device interrogation/testing will include:

  • Atrial and right/left ventricular pacing thresholds
  • P-wave and R-wave amplitude
  • Lead impedance (atrial, ventricular, high voltage)
  • Battery voltage

The need for further follow-up will be determined by the physician based on testing results and clinical need.

The results of the follow-up device interrogation, including whether MRI-related adverse events have resolved, will be documented and kept in the device chart and recorded in the Registry database.

If the insurance provider does not cover the MRI and device checks, those costs may be the full responsibility of the patient. The patient will be informed of the status of the pre-authorization before scheduling the MRI.

Being tested
MRI Scan

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRI ScanOther

    The MRI will be performed with a 1.5 T scanner utilizing institutional protocols and the following settings:

    • Normal operating mode
    • SAR ≤ 2.0 W/kg per patient.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Burning or Pulling Sensations in Chest/Device Pocket During MRI

    Measured: Through procedure completion, an average of 1 hour

  2. Number of Participants With Potentially Lethal/Previously Non-diagnosed Arrhythmias During MRI

    Measured: Through procedure completion, an average of 1 hour

  3. Number of Participants With Spontaneous and Unanticipated Pacing Rate Change

    Measured: Through procedure completion, an average of 1 hour

  4. Number of Participants With Power on Reset of Pacemaker or ICD

    Measured: Through procedure completion, an average of 1 hour

  5. Number of Participants With MRI Related Device Malfunction/Failure

    Measured: Through procedure completion, an average of 1 hour

  6. Number of Participants With Serious Injury/Death Related to MRI Device Malfunction/Failure

    Measured: Through procedure completion, an average of 1 hour

  7. Number of MRI Scans With Post-MRI Device Parameter Change: Greater Than 50 Ohm Change in Atrial or Ventricular (RV and/or LV) Lead Impedance

    Measured: Through procedure completion, an average of 1 hour

  8. Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than 5 Ohm Change in High Voltage Lead Impedance

    Measured: Through procedure completion, an average of 1 hour

  9. Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than 50% Decrease in Atrial or Ventricular (RV and/or LV) Sensing Threshold

    Measured: Through procedure completion, an average of 1 hour

  10. Number of MRI Scans With Post-MRI Device Parameter Changes: Greater Than or Equal to a 1 Volt Increase in Atrial or Ventricular (RV and/or LV) Pacing Threshold

    Measured: Through procedure completion, an average of 1 hour

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2014 (estimated)
  2. Study startDec 2014
  3. Primary completion30 Jun 2018
  4. Study completion30 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
262 participants (actual)
Target duration
6 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT02318550
Sponsor's protocol ID
2014-68
Status last verified
Aug 2021
First submitted
10 Dec 2014
Last updated
31 Aug 2021
Data monitoring committee
Yes

Publications

  • Mollerus M, Albin G, Lipinski M, Lucca J. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol. 2009 Jun;32(6):772-8. doi: 10.1111/j.1540-8159.2009.02364.x.

    PubMed 19545340
  • Nazarian S, Hansford R, Roguin A, Goldsher D, Zviman MM, Lardo AC, Caffo BS, Frick KD, Kraut MA, Kamel IR, Calkins H, Berger RD, Bluemke DA, Halperin HR. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med. 2011 Oct 4;155(7):415-24. doi: 10.7326/0003-4819-155-7-201110040-00004.

    PubMed 21969340
  • Nazarian S, Roguin A, Zviman MM, Lardo AC, Dickfeld TL, Calkins H, Weiss RG, Berger RD, Bluemke DA, Halperin HR. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation. 2006 Sep 19;114(12):1277-84. doi: 10.1161/CIRCULATIONAHA.105.607655. Epub 2006 Sep 11.

    PubMed 16966586
  • Nazarian S, Beinart R, Halperin HR. Magnetic resonance imaging and implantable devices. Circ Arrhythm Electrophysiol. 2013 Apr;6(2):419-28. doi: 10.1161/CIRCEP.113.000116. No abstract available.

    PubMed 23592868
  • Ferreira AM, Costa F, Tralhao A, Marques H, Cardim N, Adragao P. MRI-conditional pacemakers: current perspectives. Med Devices (Auckl). 2014 May 7;7:115-24. doi: 10.2147/MDER.S44063. eCollection 2014.

    PubMed 24851058

Questions about this trial

What is this clinical trial studying?

An observational study of MRI Scans and Magnetic Resonance Imaging, run by Lancaster General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 May 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Burning or Pulling Sensations in Chest/Device Pocket During MRI (time frame: Through procedure completion, an average of 1 hour). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02318550, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in